// App-Quantinova.ai

: The Determination Trial Impact on Upfront (vs Delayed) Autologous Stem Cell Transplantation for Transplant-Eligible Newly Diagnosed Multiple Myeloma

Researchers

Presenter

  • Brooke Dulka

Principal Investigators

  • ROBERT N. BONE

  • Yolaine Jeune-Smith

  • Muhamed Baljevic

  • Bruce A. Feinberg

Medical Centers

  • Vanderbilt University Medical Center, Nashville, TN

Locations

  • United States

Companies

  • Cardinal Health, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Lenalidomide

  • Bortezomib

  • Melphalan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved